We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

128 hedge funds and large institutions have $75.2M invested in Ampio Pharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

561% more call options, than puts

Call options by funds: $2.71M | Put options by funds: $410K

90% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 20

46% more capital invested

Capital invested by funds: $51.5M → $75.2M (+$23.7M)

22% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 23

16% more funds holding

Funds holding: 110 → 128 (+18)

Holders
128
Holders Change
+18
Holders Change %
+16.36%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
28
Reduced
23
Closed
20
Calls
$2.71M
Puts
$410K
Net Calls
+$2.3M
Net Calls Change
+$811K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.4M
2
State Street
State Street
Massachusetts
+$4.91M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.05M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.76M
5
Northern Trust
Northern Trust
Illinois
+$2.69M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.23M
2
HF
HRT Financial
New York
-$839K
3
ECM
ExodusPoint Capital Management
New York
-$817K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$794K
5
Citadel Advisors
Citadel Advisors
Florida
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
126
American International Group
New York
$178 +$191K +355 New
H
127
HoyleCohen
California
$17 – – –
Millennium Management
128
Millennium Management
New York
– -$3.23M -6,368 Closed
HF
129
HRT Financial
New York
– -$839K -1,657 Closed
ECM
130
ExodusPoint Capital Management
New York
– -$817K -1,612 Closed
California Public Employees Retirement System
131
California Public Employees Retirement System
California
– -$616K -1,216 Closed
Bank of Montreal
132
Bank of Montreal
Ontario, Canada
– -$662K -1,200 Closed
LP
133
LMR Partners
United Kingdom
– -$192K -380 Closed
DC
134
Diametric Capital
Massachusetts
– -$76K -150 Closed
JG
135
Jefferies Group
New York
– -$63.9K -126 Closed
SSA
136
Schonfeld Strategic Advisors
New York
– -$58K -115 Closed
Qube Research & Technologies (QRT)
137
Qube Research & Technologies (QRT)
United Kingdom
– -$57K -112 Closed
PCM
138
Prelude Capital Management
New York
– -$50K -99 Closed
CS
139
Credit Suisse
Switzerland
– -$30K -59 Closed
MS
140
Maven Securities
Jersey
– -$29K -57 Closed
SM
141
Sciencast Management
New Jersey
– -$30K -55 Closed
JMPWA
142
JP Morgan Private Wealth Advisors
California
– -$25K -50 Closed
Capstone Investment Advisors
143
Capstone Investment Advisors
New York
– -$25K -49 Closed
CHA
144
Cooper/Haims Advisors
New York
– -$17K -33 Closed
SPIA
145
Steward Partners Investment Advisory
New York
– -$12.7K -25 Closed
SFS
146
Sowell Financial Services
Arkansas
– -$10K -20 Closed
GWSG
147
GPS Wealth Strategies Group
Colorado
– -$1K -3 Closed
2 3 4 5
6

AMPE Hedge Fund Activity: Q2 2021 in Review

128 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2021, worth a combined $75.2M — up 46% from $51.5M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new AMPE positions and 20 closed out — a net gain of 18 holders — while 28 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Millennium Management, exiting entirely with an estimated $3.23M sold.

  • 128 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2021, up from 110 in Q1 2021.
  • Funds reported $75.2M of Ampio Pharmaceuticals Inc. stock for Q2 2021, up 46% quarter-over-quarter.
  • 38 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2021 and 20 closed out, a net change of +18 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2021 was BlackRock, an estimated $15.4M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2021 was Millennium Management, an estimated $3.23M sold.

Based on aggregated 13F filings for Q2 2021.